Sales of Beta Bionics insulin pumps spiked 145% in the fourth quarter behind solid new patient starts. Elsewhere, former ...
Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...
A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...
Zacks Investment Research on MSN1d
DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 ApprovalDexCom DXCM is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could affect the ...
The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...
In a new study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day ...
A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
Zacks Investment Research on MSN9d
TNDM Stock Gains on the Commercial Launch of Control-IQ+ TechnologyTandem Diabetes Care, Inc. TNDM recently commercially launched Control-IQ+ technology - the latest generation of its advanced hybrid closed-loop algorithm in the United States. Control-IQ+ is ...
The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this. No one can predict how ...
At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback